Pfizer

US CDC will not publish report showing COVID vaccine effectiveness

"Scientific reports are routinely reviewed at multiple levels to ensure they meet the highest standards before publication," said HHS spokesperson Andrew Nixon.

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020
FOUNDER OF the Genesis Prize Stan Polovets, New England Patriots owner Robert Kraft, and Morris Kahn in 2019.

'When I grow up, I want to be like you': remembering Morris Kahn's most productive years - opinion

PFIZER CEO Albert Bourla gestures at an event in the White House in September.

Grapevine, November 30, 2025: Mamdani complexities

Mohammed bin Salman of Saudi Arabia, Jensen Huang, CEO of Nvidia, and Elon Musk attend the US-Saudi Investment Forum in Washington, DC. US President Donald Trump, Crown Prince and Prime Minister.

MBS’s first Washington trip since 2018 brings new investments


European Medicines Agency recommends Novavax add warning to their COVID-19 vaccine

The European Medicines Agency (EMA) is recommending that Novavax should start putting a warning label on their COVID-19 vaccines due to a small number of reported cases of heart inflammation.

 The COVID-19 vaccine (illustrative).

AION, aMoon up for top scientific innovation award

AION Labs brings together some of the biggest names in pharma, including AstraZeneca, Merck and Pfizer, and aMoon is Israel’s largest health-tech fund.

AION Labs CEO Mati Gil.

Pfizer profit beats estimates on higher demand for COVID products

Revenue from the antiviral pill, Paxlovid, exceeded market estimates by more than $1b, while vaccine sales surged 20%, helping the drugmaker reaffirm the combined 2022 revenue forecast of $54b.

 People pose with syringe with needle in front of displayed Pfizer logo in this illustration taken.

COVID-19 booster shots are crucial, according to a Yale study

New study by Yale, UNC, shows that peak antibody levels achieved by getting vaccinated with an mRNA vaccine exceed those gained from natural infection.

A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

Pfizer CEO Dr. Albert Bourla - Jewish COVID-19 hero

Genesis Prize Deputy CEO Sana Britavsky: “Albert himself is a humble man, but also a remarkable Jewish phenomenon.”

 Dr. Albert Bourla at the King David Hotel.

US FDA allows pharmacists to prescribe Pfizer's COVID pill

Use of the pill, authorized to treat newly infected, at-risk people to prevent severe illness, has jumped in recent weeks as infections rise.

 Paxlovid, Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy

COVID-19 hero: Pfizer CEO Albert Bourla reflects on the past, future

Bourla revealed that he would donate the $1 million award to building a Holocaust museum in his hometown in an interview for The Jerusalem Post.

 DR. ALBERT BOURLA on the King David Hotel’s rooftop overlooking Jerusalem, on June 28, ahead of the Genesis Prize ceremony.

Pfizer CEO Albert Bourla receives honorary doctorate from Technion

Bourla was recognized for his exceptional leadership in developing the first safe and effective COVID-19 vaccine, which remains the gold standard for vaccines against the novel coronavirus.

 Pfizer CEO Dr. Albert Bourla at the ceremony

President of Israel Presents the 2022 'Jewish Nobel Prize' to Pfizer CEO Albert Bourla in Jerusalem

Bourla donates $1 million award towards construction of Holocaust Museum of Greece in Thessaloniki to commemorate Greek-Jewish communities wiped out by the Nazis.

  Left to right: President Isaac Herzog, founder and Chairman of The Genesis Prize Foundation Stan Polovets and Dr. Albert Bourla at Award ceremony

EU chief can't find texts with Pfizer chief on COVID-19 vaccine deal

European Commission president Ursula von der Leyen exchanged texts with Pfizer chief Albert Bourla for a month when they were negotiating a massive vaccine contract.

 President of the European Commission Ursula von der Leyen looks on as she speaks to the media in Ramallah, in the West Bank June 14, 2022.